147 related articles for article (PubMed ID: 15548711)
1. Synergistic interaction between sphingomyelin and gemcitabine potentiates ceramide-mediated apoptosis in pancreatic cancer.
Modrak DE; Cardillo TM; Newsome GA; Goldenberg DM; Gold DV
Cancer Res; 2004 Nov; 64(22):8405-10. PubMed ID: 15548711
[TBL] [Abstract][Full Text] [Related]
2. Ceramide regulates gemcitabine-induced senescence and apoptosis in human pancreatic cancer cell lines.
Modrak DE; Leon E; Goldenberg DM; Gold DV
Mol Cancer Res; 2009 Jun; 7(6):890-6. PubMed ID: 19531570
[TBL] [Abstract][Full Text] [Related]
3. Study of apoptosis induction and deoxycytidine kinase/cytidine deaminase modulation in the synergistic interaction of a novel ceramide analog and gemcitabine in pancreatic cancer cells.
Giovannetti E; Leon LG; Bertini S; Macchia M; Minutolo F; Funel N; Alecci C; Giancola F; Danesi R; Peters GJ
Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):419-26. PubMed ID: 20544530
[TBL] [Abstract][Full Text] [Related]
4. Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer.
Jiang Y; DiVittore NA; Kaiser JM; Shanmugavelandy SS; Fritz JL; Heakal Y; Tagaram HR; Cheng H; Cabot MC; Staveley-O'Carroll KF; Tran MA; Fox TE; Barth BM; Kester M
Cancer Biol Ther; 2011 Oct; 12(7):574-85. PubMed ID: 21795855
[TBL] [Abstract][Full Text] [Related]
5. LCL124, a cationic analog of ceramide, selectively induces pancreatic cancer cell death by accumulating in mitochondria.
Beckham TH; Lu P; Jones EE; Marrison T; Lewis CS; Cheng JC; Ramshesh VK; Beeson G; Beeson CC; Drake RR; Bielawska A; Bielawski J; Szulc ZM; Ogretmen B; Norris JS; Liu X
J Pharmacol Exp Ther; 2013 Jan; 344(1):167-78. PubMed ID: 23086228
[TBL] [Abstract][Full Text] [Related]
6. Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation. Does sphingomyelin synthase account for the putative phosphatidylcholine-specific phospholipase C?
Luberto C; Hannun YA
J Biol Chem; 1998 Jun; 273(23):14550-9. PubMed ID: 9603970
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the activity and fatty acid specificity of lecithin-cholesterol acyltransferase by sphingomyelin and its metabolites, ceramide and ceramide phosphate.
Subbaiah PV; Horvath P; Achar SB
Biochemistry; 2006 Apr; 45(15):5029-38. PubMed ID: 16605271
[TBL] [Abstract][Full Text] [Related]
8. Ceramide metabolism determines glioma cell resistance to chemotherapy.
Dumitru CA; Weller M; Gulbins E
J Cell Physiol; 2009 Dec; 221(3):688-95. PubMed ID: 19711353
[TBL] [Abstract][Full Text] [Related]
9. Sphingomyelinase and membrane sphingomyelin content: determinants ofProximal tubule cell susceptibility to injury.
Zager RA; Burkhart KM; Johnson A
J Am Soc Nephrol; 2000 May; 11(5):894-902. PubMed ID: 10770967
[TBL] [Abstract][Full Text] [Related]
10. In vitro effects of fat, FA, and cholesterol on sphingomyelin hydrolysis induced by rat intestinal alkaline sphingomyelinase.
Liu JJ; Nilsson A; Duan RD
Lipids; 2002 May; 37(5):469-74. PubMed ID: 12056588
[TBL] [Abstract][Full Text] [Related]
11. Alteration of the daunorubicin-triggered sphingomyelin-ceramide pathway and apoptosis in MDR cells: influence of drug transport abnormalities.
Côme MG; Bettaieb A; Skladanowski A; Larsen AK; Laurent G
Int J Cancer; 1999 May; 81(4):580-7. PubMed ID: 10225448
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of gene expression levels of ceramide metabolic enzymes after application of sphingomyelin-based liposomes to a three-dimensional cultured human epidermis model.
Itaya Y; Tokudome Y
Biochem Biophys Res Commun; 2016 Apr; 473(1):114-117. PubMed ID: 26995090
[TBL] [Abstract][Full Text] [Related]
13. Increase of nuclear ceramide through caspase-3-dependent regulation of the "sphingomyelin cycle" in Fas-induced apoptosis.
Watanabe M; Kitano T; Kondo T; Yabu T; Taguchi Y; Tashima M; Umehara H; Domae N; Uchiyama T; Okazaki T
Cancer Res; 2004 Feb; 64(3):1000-7. PubMed ID: 14871831
[TBL] [Abstract][Full Text] [Related]
14. Role of ceramide/sphingomyelin (SM) balance regulated through "SM cycle" in cancer.
Taniguchi M; Okazaki T
Cell Signal; 2021 Nov; 87():110119. PubMed ID: 34418535
[TBL] [Abstract][Full Text] [Related]
15. Withanolide D induces apoptosis in leukemia by targeting the activation of neutral sphingomyelinase-ceramide cascade mediated by synergistic activation of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase.
Mondal S; Mandal C; Sangwan R; Chandra S; Mandal C
Mol Cancer; 2010 Sep; 9():239. PubMed ID: 20836852
[TBL] [Abstract][Full Text] [Related]
16. Ceramide potentiates, but sphingomyelin inhibits, vitamin D-induced keratinocyte differentiation: comparison between keratinocytes and HL-60 cells.
Pillai S; Mahajan M; Carlomusto M
Arch Dermatol Res; 1999 May; 291(5):284-9. PubMed ID: 10367711
[TBL] [Abstract][Full Text] [Related]
17. Gangliosides link the acidic sphingomyelinase-mediated induction of ceramide to 12-lipoxygenase-dependent apoptosis of neuroblastoma in response to fenretinide.
Lovat PE; Di Sano F; Corazzari M; Fazi B; Donnorso RP; Pearson AD; Hall AG; Redfern CP; Piacentini M
J Natl Cancer Inst; 2004 Sep; 96(17):1288-99. PubMed ID: 15339967
[TBL] [Abstract][Full Text] [Related]
18. The group VIA calcium-independent phospholipase A2 participates in ER stress-induced INS-1 insulinoma cell apoptosis by promoting ceramide generation via hydrolysis of sphingomyelins by neutral sphingomyelinase.
Lei X; Zhang S; Bohrer A; Bao S; Song H; Ramanadham S
Biochemistry; 2007 Sep; 46(35):10170-85. PubMed ID: 17685585
[TBL] [Abstract][Full Text] [Related]
19. Triciribine Phosphate Monohydrate, an AKT Inhibitor, Enhances Gemcitabine Activity in Pancreatic Cancer Cells.
Kim R; Yamauchi T; Husain K; Sebti S; Malafa M
Anticancer Res; 2015 Sep; 35(9):4599-604. PubMed ID: 26254348
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 beta stimulates sphingomyelin hydrolysis in cultured granulosa cells: evidence for a regulatory role of ceramide on progesterone and prostaglandin biosynthesis.
Santana P; Llanes L; Hernandez I; Gonzalez-Robayna I; Tabraue C; Gonzalez-Reyes J; Quintana J; Estevez F; Ruiz de Galarreta CM; Fanjul LF
Endocrinology; 1996 Jun; 137(6):2480-9. PubMed ID: 8641202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]